By Amy Norton
HealthDay Reporter

MONDAY, March 30, 2020 (HealthDay Information) — A little study out of China bolsters the idea that transfusing the antibody-enriched blood of persons who’ve survived COVID-19 could aid individuals even now combating for their life from the disease.

The study of five critically sick individuals from near the original epicenter of the novel coronavirus pandemic observed that all five individuals survived COVID-19 subsequent the transfusion.

If the conclusions are replicated in larger trials, widespread use of the treatment method “could aid transform the course of this pandemic,” wrote Drs. John Roback and Jeannette Guarner of